Literature DB >> 21417775

Nisin and class IIa bacteriocin resistance among Listeria and other foodborne pathogens and spoilage bacteria.

Gurpreet Kaur1, Ravinder Kumar Malik, Santosh Kumar Mishra, Tejinder Pal Singh, Arun Bhardwaj, Garima Singroha, Shilpa Vij, Naresh Kumar.   

Abstract

Food safety has been an important issue globally due to increasing foodborne diseases and change in food habits. To inactivate foodborne pathogens, various novel technologies such as biopreservation systems have been studied. Bacteriocins are ribosomally synthesized peptides or proteins with antimicrobial activity produced by different groups of bacteria, but the bacteriocins produced by many lactic acid bacteria offer potential applications in food preservation. The use of bacteriocins in the food industry can help reduce the addition of chemical preservatives as well as the intensity of heat treatments, resulting in foods that are more naturally preserved. However, the development of highly tolerant and/or resistant strains may decrease the efficiency of bacteriocins as biopreservatives. Several mechanisms of bacteriocin resistance development have been proposed among various foodborne pathogens. The acquiring of resistance to bacteriocins can significantly affect physiological activity profile of bacteria, alter cell-envelope lipid composition, and also modify the antibiotic susceptibility/resistance profile of bacteria. This article presents a brief review on the scientific research about the various possible mechanisms involved in the development of resistance to nisin and Class IIa bacteriocins among the foodborne pathogens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21417775     DOI: 10.1089/mdr.2010.0054

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

1.  A novel enterocin T1 with anti-Pseudomonas activity produced by Enterococcus faecium T1 from Chinese Tibet cheese.

Authors:  Hui Liu; Lanwei Zhang; Huaxi Yi; Xue Han; Wei Gao; Chunliang Chi; Wei Song; Haiying Li; Chunguang Liu
Journal:  World J Microbiol Biotechnol       Date:  2016-01-08       Impact factor: 3.312

2.  Antibacterial efficacy of nisin, pediocin 34 and enterocin FH99 against L. monocytogenes, E. faecium and E. faecalis and bacteriocin cross resistance and antibiotic susceptibility of their bacteriocin resistant variants.

Authors:  Gurpreet Kaur; Tejinder Pal Singh; Ravinder Kumar Malik; Arun Bhardwaj; Sachinandan De
Journal:  J Food Sci Technol       Date:  2011-09-02       Impact factor: 2.701

3.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30

4.  Insect Antimicrobial Peptide Complexes Prevent Resistance Development in Bacteria.

Authors:  Sergey Chernysh; Natalia Gordya; Tatyana Suborova
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 5.  Bacteriocins, Antimicrobial Peptides from Bacterial Origin: Overview of Their Biology and Their Impact against Multidrug-Resistant Bacteria.

Authors:  Alexis Simons; Kamel Alhanout; Raphaël E Duval
Journal:  Microorganisms       Date:  2020-04-27

Review 6.  Class IIa bacteriocins: diversity and new developments.

Authors:  Yanhua Cui; Chao Zhang; Yunfeng Wang; John Shi; Lanwei Zhang; Zhongqing Ding; Xiaojun Qu; Hongyu Cui
Journal:  Int J Mol Sci       Date:  2012-12-06       Impact factor: 5.923

7.  Effects of natural antimicrobials with modified atmosphere packaging on the growth kinetics of Listeria monocytogenes in ravioli at various temperatures.

Authors:  Eun Young Ro; Geun Su Kim; Do Young Kwon; Young Min Park; Sang Woo Cho; Sang Yun Lee; Ik Hyun Yeo; Ki Sun Yoon
Journal:  J Food Saf       Date:  2017-08-25       Impact factor: 1.953

8.  The Effect of Carbohydrates and Bacteriocins on the Growth Kinetics and Resistance of Listeria monocytogenes.

Authors:  Danielle R Balay; Michael G Gänzle; Lynn M McMullen
Journal:  Front Microbiol       Date:  2018-03-01       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.